Ciprofloxacin Tablet
Product Images NDC 67296-2135

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ciprofloxacin (NDC 67296-2135). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

C17h18fn3o3•hcl•h2o (Image 01)

FDA Label Image

C17h18fn3o3 (Image 02)

FDA Label Image

250 mg (Image 03)

Each film-coated tablet of this medication contains Ciprofloxacin Hydrochloride USP equivalent to 250 mg of ciprofloxacin. The usual dosage instructions can be found in the package insert. The storage recommendation is between 20°C to 25°C (68°F to 77°F). It should be preserved in well-closed containers at controlled room temperature. For more detailed information, the medication guide can be viewed at www.solcohealthcare.com/medguide/ciprofloxacin-tablets.pdf. Manufacturing is done by Yiling Pharmaceutical Ltd in China, while Solco Healthcare US, LLC distributed it from Somerset, NJ, USA. This information was last revised in July 2023.*

FDA Label Image

500 mg (Image 04)

Each film-coated tablet of this medication contains 500 mg of ciprofloxacin hydrochloride. The usual dosage information can be found in the package insert. It is recommended to store the tablets at 20°C to 25°C and keep them in well-closed containers. For more details, refer to the medication guide available at www.solcohealthcare.com. This product is manufactured in China and distributed by Solco Healthcare US, LLC in the USA. Remember to provide each patient with the medication guide separately.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.